Helen Louise Collins insider trades: Enliven Therapeutics (ELVN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Helen reports to the SEC
Open-market buys and sales
11 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 19, 2026 | ELVN | ↓ Sell | 5,000 | $38.47 | $192K | Direct | Oct 21, 2026 (2d) |
| Sep 17, 2026 | ELVN | ↓ Sell | 5,000 | $50.35 | $252K | Direct | Sep 21, 2026 (4d) |
| Aug 17, 2026 | ELVN | ↓ Sell | 5,000 | $58.59 | $293K | Direct | Aug 19, 2026 (2d) |
| Jul 17, 2026 | ELVN | ↓ Sell | 5,000 | $52.67 | $263K | Direct | Jul 21, 2026 (4d) |
| Jun 17, 2026 | ELVN | ↓ Sell | 5,000 | $43.80 | $219K | Direct | Jun 22, 2026 (5d) |
| May 18, 2026 | ELVN | ↓ Sell | 5,000 | $39.79 | $199K | Direct | May 20, 2026 (2d) |
| Apr 17, 2026 | ELVN | ↓ Sell | 5,000 | $47.67 | $238K | Direct | Apr 21, 2026 (4d) |
| Mar 10, 2026 | ELVN | ↓ Sell | 40,000 | $30.07 | $1.2M | Direct | Mar 11, 2026 (1d) |
| Feb 17, 2026 | ELVN | ↓ Sell | 45,000 | $26.17 | $1.2M | Direct | Feb 19, 2026 (2d) |
| Oct 18, 2024 | ELVN | ↓ Sell | 816 | $30.00 | $24K | Direct | Oct 22, 2024 (4d) |
| Apr 11, 2024 | ELVN | ↓ Sell | 20,000 | $25.07 | $501K | Direct | Apr 15, 2024 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ELVN insiders
Open-market trades in the last 12 months
About Helen Louise Collins's insider trades
Helen Louise Collins is Chief Medical Officer at Enliven Therapeutics (ELVN). Since Apr 11, 2024, Helen has reported no open-market purchases and 11 sales worth $4.6M on SEC Form 4. In the last 12 months: 9 sales ($4.0M).
Their filings also include grants and awards (22 filings), shares withheld for taxes (18 filings), option exercises (13 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELVN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.